|
|
|
Location: Home -
Products - Active Pharma Ingredients(API) - Antibiotic agents
|
Daptomycin(LY 146032)
Catalogue No. : |
C13534 |
Product Name: |
Daptomycin(LY 146032) |
Synonym: |
LY 146032 |
Chemical Name: |
N-(1-Oxodecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithinyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-α,2-diamino-γ-oxo-benzene butanoic acid (13-4) lactone |
CAS No. : |
103060-53-3 |
Structure : |
|
Molecular Formula: |
C72H101N17O26 |
Molecular Weight: |
1620.67 |
Purity: |
>98% |
Usage: |
Lipopeptide, calcium-dependent antibiotic. Exhibits potent bacteriocidal activity against most gram-positive bacteria in vitro and in vivo, including antibiotic-resistant strains such as MRSA and VRE. Disrupts plasma membrane function; activity results in membrane depolarization leading to inhibition of protein, DNA and RNA synthesis. |
|
Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|